Ser384

Site Information
SDRQLsEsStkDsLk SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 10852180

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	breast cancer ( 2 ) , breast ductal carcinoma ( 2 )
Relevant cell line - cell type - tissue:	breast ( 2 ) , HeLa (cervical) ( 1 ) , Jurkat (T lymphocyte) ( 3 )

Upstream Regulation
Treatments:	ischemia ( 2 )

References
1	Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94 25159151 Curated Info
2	Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704 24719451 Curated Info
3	Possemato A (2009) CST Curation Set: 6744; Year: 2009; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (K/R)XX[ST] Curated Info